[Studies on the course of megaloblastic anemias under vitamin B 12 treatment].
D000368:Aged; D000752:Anemia, Pernicious / Q000188:drug therapy* / Q000201:enzymology; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D004247:DNA / Q000096:biosynthesis; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D005260:Female; D006041:Goats; D006801:Humans; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D008892:Milk; D009101:Multiple Myeloma / Q000188:drug therapy*; D013762:Tetrahydrofolate Dehydrogenase / Q000097:blood; D013937:Thymidine Kinase / Q000097:blood; D014805:Vitamin B 12 / Q000627:therapeutic use*; D014806:Vitamin B 12 Deficiency / Q000188:drug therapy* / Q000201:enzymology
D007527:Isoenzymes; D004247:DNA; D007770:L-Lactate Dehydrogenase; D013762:Tetrahydrofolate Dehydrogenase; D013937:Thymidine Kinase; D014805:Vitamin B 12
Verlaufsstudien an megaloblastären Anämien unter Vitamin-B12-Behandlung.